retatrutide mechanism clinical trials

retatrutide mechanism clinical trials Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA GLP-3 Retatrutide · Disguised Alpha

Name: retatrutide mechanism clinical trials Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA GLP-3 Retatrutide · Disguised Alpha
Brand: www.himachallive.in
SKU: 92875401313
Price: 21.77 USD
Availability: InStock
Rating: 4.7452000000000005 (11 reviews)

SKU: 92875401313

4.7

EUR21.77 EUR46.77

Pay in 4 interest-free payments of $5.44 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

Description

Incretin therapies target the class B G protein-coupled receptors GLP-1R and GIPR, expressed mainly in the pancreas and the hypothalamus, while some therapeutical approaches include additional targeting of the related glucagon receptor (GCGR) in the liver